EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Survival and safety evaluation of Bifidobacterium longum subsp . longum ZS-8 in healthy adults, determined using PMAxx-qPCR and amplicon sequencing

Feng Liu iD, Biao Dong, Zhongsun Wang, Dan Lin, Huan Xu, Baisheng Ke, Wanying Kang, Yang Jin, Xiuting Huang, Hui Lu, Liqing Zhao, Yun Qian und 3 weitere

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.02861-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Feng Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Food Science and Technology, Nanchang University, Nanchang, People's Republic of China. Hauptthemen laut MEDLINE: Probiotics, Microbial Viability, Bifidobacterium, Real-Time Polymerase Chain Reaction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Species-level quantitative PCR (qPCR) provides in-depth knowledge of oral probiotics in the human gastrointestinal tract (GIT). However, it lacks the capability to differentiate exogenous strains from native microbiota, nor can it distinguish between live and dead bacteria. In this study, we employed improved propidium monoazide (PMAxx)-qPCR to evaluate the survival and colonization of Bifidobacterium longum subsp . longum ZS-8 (designated ZS-8) on the strain level in the GIT and its impact on human gut microbiota. By spiking in live and dead ZS-8, we demonstrated that strain-level PMAxx-qPCR could identify and quantify the viable ZS-8 in fecal samples accurately. Using this method, we found that, in healthy humans, oral administration of ZS-8 can transiently survive in the GIT, and multi-layer seamless capsules (MLSC) significantly improve the gastrointestinal tolerance and survivability of ZS-8 compared to its powder form. Furthermore, through selective cultivation and PMAxx-microbiome sequencing, we investigated the response of gut viable microbiome to ZS-8. Results showed that, while the microbiota diversity and total viable counts of Bifidobacterium and Lactobacillus remained stable, certain indigenous species of Bifidobacterium and Lactobacillus increased in abundance, confirming ZS-8's probiotic potential in healthy individuals. Overall, our study demonstrates the effectiveness of combining strain-specific comparative genomics with PMAxx-qPCR for evaluating probiotic survival and colonization in the human gut and highlights the safety of ZS-8 oral administration in healthy individuals. IMPORTANCE The survival and colonization of probiotics in the gut are critical for their functional efficacy, yet conventional species-level quantitative PCR (qPCR) fails to distinguish exogenous strains from native microbiota or differentiate live from dead bacteria. By integrating strain-specific comparative genomics with propidium monoazide (PMAxx)-qPCR, we precisely quantified the viability of Bifidobacterium longum ZS-8 at the strain level in the human gut after its oral administration. Our study demonstrated that 1.53–6.90% of cells surviving transit and multi-layer seamless capsules (MLSC) significantly enhanced the gastrointestinal tolerance of ZS-8. While ZS-8 administration did not alter gut microbiota diversity or total viable counts of Bifidobacterium and Lactobacillus , it selectively increased the abundance of specific indigenous beneficial species. This method overcomes the dual limitations of traditional techniques (strain-level specificity and viability discrimination), providing a robust tool for probiotic research. Furthermore, our findings confirm the safety of ZS-8 in healthy individuals and its potential to modulate gut ecology, offering a scientific foundation for personalized probiotic development and clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsMicrobial ViabilityBifidobacteriumReal-Time Polymerase Chain ReactionBifidobacterium longumHumansAdultFecesGastrointestinal MicrobiomeHealthy VolunteersGastrointestinal TractPropidiumAzidesMaleFemaleYoung AdultAdministration, Oral

Stichwörter der Autor:innen

PMAxxgut microbiotalive/dead bacteriaprobiotics

Substanzen

propidium monoazidePropidiumAzides

Autor:innen und Institutionen

  • State Key Laboratory of Food Science and Technology, Nanchang University, Nanchang, People's Republic of China.
  • Shenzhen Wanhe Pharmaceutical Co., Ltd., Shenzhen, People's Republic of China.
  • Department of Gastroenterology and Hepatology, Shenzhen University General Hospital, Shenzhen, People's Republic of China.
  • College of Bioscience and Bioengineering, Jiangxi Agricultural University, Nanchang, People's Republic of China.
  • Department of Food Science and Engineering, College of Chemistry and Environmental Engineering, Shenzhen University, Shenzhen, People's Republic of China.
  • Marshall Laboratory of Biomedical Engineering, Shenzhen University, Shenzhen, People's Republic of China.

ORCID-Profile: Feng Liu, Long Xu, Zhenjiang Zech Xu

Zitieren

APA

Liu, F., Dong, B., Wang, Z., Lin, D., Xu, H., Ke, B., Kang, W., Jin, Y., Huang, X., Lu, H., Zhao, L., Qian, Y., Cai, L., Xu, L., & Xu, Z. Z. (2025). Survival and safety evaluation of Bifidobacterium longum subsp . longum ZS-8 in healthy adults, determined using PMAxx-qPCR and amplicon sequencing. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02861-24

Vancouver

Liu F, Dong B, Wang Z, Lin D, Xu H, Ke B, et al. Survival and safety evaluation of Bifidobacterium longum subsp . longum ZS-8 in healthy adults, determined using PMAxx-qPCR and amplicon sequencing. Microbiology Spectrum. 2025. doi:10.1128/spectrum.02861-24

BibTeX
@article{Liu2025,
  author = {Liu, Feng and Dong, Biao and Wang, Zhongsun and Lin, Dan and Xu, Huan and Ke, Baisheng and Kang, Wanying and Jin, Yang and Huang, Xiuting and Lu, Hui and Zhao, Liqing and Qian, Yun and Cai, Liangling and Xu, Long and Xu, Zhenjiang Zech},
  title = {Survival and safety evaluation of Bifidobacterium longum subsp . longum ZS-8 in healthy adults, determined using PMAxx-qPCR and amplicon sequencing},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.02861-24}
}
Kostenlos starten →